Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Head and Neck Cancer

Free Subscription Articles published in Clin Cancer Res Retrieve available abstracts of 105 articles: HTML format

Single Articles

May 2008
1. ZHANG X , Komaki R, Wang L, Fang B, et al
   Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.
   Clin Cancer Res. 2008;14:2813-23.
   PubMed     Related articles    Abstract available
   
   
   April 2008
2. PAVLOVA I , Williams M, El-Naggar A, Richards-Kortum R, et al
   Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue.
   Clin Cancer Res. 2008;14:2396-404.
   PubMed     Related articles    Abstract available
   
   
   
3. MARSIT CJ , Black CC, Posner MR, Kelsey KT, et al
   A genotype-phenotype examination of cyclin d1 on risk and outcome of squamous cell carcinoma of the head and neck.
   Clin Cancer Res. 2008;14:2371-7.
   PubMed     Related articles    Abstract available
   
   
   March 2008
4. GU X , Song X, Dong Y, Cai H, et al
   Vitamin E Succinate Induces Ceramide-Mediated Apoptosis in Head and Neck Squamous Cell Carcinoma In vitro and In vivo.
   Clin Cancer Res. 2008;14:1840-8.
   PubMed     Related articles    Abstract available
   
   
   
5. SEETHALA RR , Gooding WE, Handler PN, Collins B, et al
   Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes.
   Clin Cancer Res. 2008;14:1303-9.
   PubMed     Related articles    Abstract available
   
   
   February 2008
6. PATEL V , Hood BL, Molinolo AA, Lee NH, et al
   Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression.
   Clin Cancer Res. 2008;14:1002-14.
   PubMed     Related articles    Abstract available
   
   
   January 2008
7. KLOPPER JP , Berenz A, Hays WR, Sharma V, et al
   In vivo and Microarray Analysis of Rexinoid-Responsive Anaplastic Thyroid Carcinoma.
   Clin Cancer Res. 2008;14:589-596.
   PubMed     Related articles    Abstract available
   
   
   
8. CHENG AL , Huang WG, Chen ZC, Peng F, et al
   Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis.
   Clin Cancer Res. 2008;14:435-445.
   PubMed     Related articles    Abstract available
   
   
   
9. WESTRA WH , Taube JM, Poeta ML, Begum S, et al
   Inverse Relationship between Human Papillomavirus-16 Infection and Disruptive p53 Gene Mutations in Squamous Cell Carcinoma of the Head and Neck.
   Clin Cancer Res. 2008;14:366-9.
   PubMed     Related articles    Abstract available
   
   
   
10. BOULT J , Roberts K, Brookes MJ, Hughes S, et al
    Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma.
    Clin Cancer Res. 2008;14:379-87.
    PubMed     Related articles    Abstract available
    
    
    
11. CARVALHO AL , Jeronimo C, Kim MM, Henrique R, et al
    Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
    Clin Cancer Res. 2008;14:97-107.
    PubMed     Related articles    Abstract available
    
    
    
12. SACKETT MK , Bairati I, Meyer F, Jobin E, et al
    Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
    Clin Cancer Res. 2008;14:67-73.
    PubMed     Related articles    Abstract available
    
    
    December 2007
13. MITHANI SK , Smith IM, Zhou S, Gray A, et al
    Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer.
    Clin Cancer Res. 2007;13:7335-40.
    PubMed     Related articles    Abstract available
    
    
    
14. COUCH ME , Ferris RL, Brennan JA, Koch WM, et al
    Alteration of Cellular and Humoral Immunity by Mutant p53 Protein and Processed Mutant Peptide in Head and Neck Cancer.
    Clin Cancer Res. 2007;13:7199-206.
    PubMed     Related articles    Abstract available
    
    
    
15. THOMAS F , Rochaix P, Benlyazid A, Sarini J, et al
    Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinoma.
    Clin Cancer Res. 2007;13:7086-92.
    PubMed     Related articles    Abstract available
    
    
    November 2007
16. KIM MS , Yamashita K, Chae YK, Tokumaru Y, et al
    A Promoter Methylation Pattern in the N-Methyl-D-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Clin Cancer Res. 2007;13:6658-6665.
    PubMed     Related articles    Abstract available
    
    
    
17. BEER AJ , Grosu AL, Carlsen J, Kolk A, et al
    [18F]Galacto-RGD Positron Emission Tomography for Imaging of {alpha}v{beta}3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and Neck.
    Clin Cancer Res. 2007;13:6610-6616.
    PubMed     Related articles    Abstract available
    
    
    
18. FRIEDMAN J , Nottingham L, Duggal P, Pernas FG, et al
    Deficient TP53 Expression, Function, and Cisplatin Sensitivity Are Restored by Quinacrine in Head and Neck Cancer.
    Clin Cancer Res. 2007;13:6568-6578.
    PubMed     Related articles    Abstract available
    
    
    
19. RICHEY LM , George JR, Couch ME, Kanapkey BK, et al
    Defining Cancer Cachexia in Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2007;13:6561-6567.
    PubMed     Related articles    Abstract available
    
    
    
20. ITEN F , Muller B, Schindler C, Rochlitz C, et al
    Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial.
    Clin Cancer Res. 2007;13:6696-6702.
    PubMed     Related articles    Abstract available
    
    
    
21. TSE KP , Tsang NM, Chen KD, Li HP, et al
    MCP-1 Promoter Polymorphism at 2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment.
    Clin Cancer Res. 2007;13:6320-6326.
    PubMed     Related articles    Abstract available
    
    
    
22. STRAUSS L , Bergmann C, Gooding W, Johnson JT, et al
    The Frequency and Suppressor Function of CD4+CD25highFoxp3+ T Cells in the Circulation of Patients with Squamous Cell Carcinoma of the Head and Neck.
    Clin Cancer Res. 2007;13:6301-6311.
    PubMed     Related articles    Abstract available
    
    
    
23. JIN Z , Olaru A, Yang J, Sato F, et al
    Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer.
    Clin Cancer Res. 2007;13:6293-6300.
    PubMed     Related articles    Abstract available
    
    
    
24. GIBCUS JH , Menkema L, Mastik MF, Hermsen MA, et al
    Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.
    Clin Cancer Res. 2007;13:6257-66.
    PubMed     Related articles    Abstract available
    
    
    October 2007
25. GROSS ND , Boyle JO, Du B, Kekatpure VD, et al
    Inhibition of Jun NH2-Terminal Kinases Suppresses the Growth of Experimental Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2007;13:5910-5917.
    PubMed     Related articles    Abstract available
    
    
    
26. LEE TL , Yang XP, Yan B, Friedman J, et al
    A Novel Nuclear Factor-{kappa}B Gene Signature Is Differentially Expressed in Head and Neck Squamous Cell Carcinomas in Association with TP53 Status.
    Clin Cancer Res. 2007;13:5680-5691.
    PubMed     Related articles    Abstract available
    
    
    
27. FERRIS RL , Grandis JR
    NF-{kappa}B Gene Signatures and p53 Mutations in Head and Neck Squamous Cell Carcinoma.
    Clin Cancer Res. 2007;13:5663-4.
    PubMed     Related articles   
    
    
    
28. FERRY DR , Anderson M, Beddard K, Tomlinson S, et al
    A phase II study of gefitinib monotherapy in advanced esophageal adenocarcinoma: evidence of gene expression, cellular, and clinical response.
    Clin Cancer Res. 2007;13:5869-75.
    PubMed     Related articles    Abstract available
    
    
    September 2007
29. DVORAK K , Chavarria M, Payne CM, Ramsey L, et al
    Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
    Clin Cancer Res. 2007;13.
    PubMed     Related articles    Abstract available
    
    
    
30. MARTONE T , Gillio-Tos A, De Marco L, Fiano V, et al
    Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
    Clin Cancer Res. 2007;13:5089-94.
    PubMed     Related articles    Abstract available
    
    
    
31. MAEDA G , Chiba T, Kawashiri S, Satoh T, et al
    Epigenetic Inactivation of I{kappa}B Kinase-{alpha} in Oral Carcinomas and Tumor Progression.
    Clin Cancer Res. 2007;13:5041-5047.
    PubMed     Related articles    Abstract available
    
    
    
32. HOUALI K , Wang X, Shimizu Y, Djennaoui D, et al
    A New Diagnostic Marker for Secreted Epstein-Barr Virus Encoded LMP1 and BARF1 Oncoproteins in the Serum and Saliva of Patients with Nasopharyngeal Carcinoma.
    Clin Cancer Res. 2007;13:4993-5000.
    PubMed     Related articles    Abstract available
    
    
    
33. MOLINOLO AA , Hewitt SM, Amornphimoltham P, Keelawat S, et al
    Dissecting the akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative.
    Clin Cancer Res. 2007;13:4964-73.
    PubMed     Related articles    Abstract available
    
    
    
34. MARTIN RC , Liu Q, Wo JM, Ray MB, et al
    Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by the manganese superoxide dismutase supplementation.
    Clin Cancer Res. 2007;13:5176-82.
    PubMed     Related articles    Abstract available
    
    
    
35. RAUSER S , Weis R, Braselmann H, Feith M, et al
    Significance of HER2 low-level copy gain in Barrett's cancer: implications for fluorescence in situ hybridization testing in tissues.
    Clin Cancer Res. 2007;13:5115-23.
    PubMed     Related articles    Abstract available
    
    
    
36. VAN WAES C , Yu M, Nottingham L, Karin M, et al
    Inhibitor-kappaB kinase in tumor promotion and suppression during progression of squamous cell carcinoma.
    Clin Cancer Res. 2007;13:4956-9.
    PubMed     Related articles   
    
    
    August 2007
37. KONDO T , Zhu X, Asa SL, Ezzat S, et al
    The Cancer/Testis Antigen Melanoma-Associated Antigen-A3/A6 Is a Novel Target of Fibroblast Growth Factor Receptor 2-IIIb through Histone H3 Modifications in Thyroid Cancer.
    Clin Cancer Res. 2007;13:4713-20.
    PubMed     Related articles    Abstract available
    
    
    
38. VAN DEN BROEK GB , Wreesmann VB, van den Brekel MW, Rasch CR, et al
    Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma.
    Clin Cancer Res. 2007;13:4386-91.
    PubMed     Related articles    Abstract available
    
    
    
39. MITHANI SK , Taube JM, Zhou S, Smith IM, et al
    Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer.
    Clin Cancer Res. 2007;13:4331-5.
    PubMed     Related articles    Abstract available
    
    
    
40. COHEN EE
    A disturbance in the force mitochondrial mutations in squamous cell carcinoma of the head and neck.
    Clin Cancer Res. 2007;13:4317-9.
    PubMed     Related articles   
    
    
    
41. GOMEZ-RIVERA F , Santillan-Gomez AA, Younes MN, Kim S, et al
    The Tyrosine Kinase Inhibitor, AZD2171, Inhibits Vascular Endothelial Growth Factor Receptor Signaling and Growth of Anaplastic Thyroid Cancer in an Orthotopic Nude Mouse Model.
    Clin Cancer Res. 2007;13:4519-27.
    PubMed     Related articles    Abstract available
    
    
    
42. SHIEH TM , Lin SC, Liu CJ, Chang SS, et al
    Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis.
    Clin Cancer Res. 2007;13.
    PubMed     Related articles    Abstract available
    
    
    
43. STRAUSS L , Bergmann C, Szczepanski M, Gooding W, et al
    A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Clin Cancer Res. 2007;13.
    PubMed     Related articles    Abstract available
    
    
    July 2007
44. CHEN K , Hu Z, Wang LE, Zhang W, et al
    Polymorphic TP53BP1 and TP53 Gene Interactions Associated with Risk of Squamous Cell Carcinoma of the Head and Neck.
    Clin Cancer Res. 2007;13:4300-5.
    PubMed     Related articles    Abstract available
    
    
    
45. BARNES CJ , Ohshiro K, Rayala SK, El-Naggar AK, et al
    Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer.
    Clin Cancer Res. 2007;13:4291-9.
    PubMed     Related articles    Abstract available
    
    
    
46. KANG SY , Han JH, Lee KJ, Choi JH, et al
    Low Expression of Bax Predicts Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Treated with Definitive Chemoradiotherapy.
    Clin Cancer Res. 2007;13:4146-4153.
    PubMed     Related articles    Abstract available
    
    
    
47. NOZOE T , Oyama T, Takenoyama M, Hanagiri T, et al
    Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus.
    Clin Cancer Res. 2007;13:4046-50.
    PubMed     Related articles    Abstract available
    
    
    
48. LIU T , Ding Y, Xie W, Li Z, et al
    An imageable metastatic treatment model of nasopharyngeal carcinoma.
    Clin Cancer Res. 2007;13:3960-7.
    PubMed     Related articles    Abstract available
    
    
    
49. HANDRA-LUCA A , Hernandez J, Mountzios G, Taranchon E, et al
    Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma
    Clin Cancer Res. 2007;13:3855-9.
    PubMed     Related articles    Abstract available
    
    
    June 2007
50. WANG Y , Spitz MR, Lee JJ, Huang M, et al
    Nucleotide excision repair pathway genes and oral premalignant lesions.
    Clin Cancer Res. 2007;13:3753-8.
    PubMed     Related articles    Abstract available
    
    
    
51. BIGBEE WL , Grandis JR, Siegfried JM
    Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients.
    Clin Cancer Res. 2007;13:3107-8.
    PubMed     Related articles   
    
    
    
52. LEE J , Suh C, Huh J, Jun HJ, et al
    Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-type.
    Clin Cancer Res. 2007;13:3250-4.
    PubMed     Related articles    Abstract available
    
    
    
53. ALLEN C , Duffy S, Teknos T, Islam M, et al
    Nuclear factor-kappaB-related serum factors as longitudinal biomarkers of response and survival in advanced oropharyngeal carcinoma.
    Clin Cancer Res. 2007;13:3182-90.
    PubMed     Related articles    Abstract available
    
    
    
54. VEKONY H , Ylstra B, Wilting SM, Meijer GA, et al
    DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma.
    Clin Cancer Res. 2007;13:3133-9.
    PubMed     Related articles    Abstract available
    
    
    May 2007
55. CHOE MS , Chen Z, Klass CM, Zhang X, et al
    Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck.
    Clin Cancer Res. 2007;13:3015-23.
    PubMed     Related articles    Abstract available
    
    
    
56. LIU Z , Jiang M, Zhao J, Ju H, et al
    Circulating tumor cells in perioperative esophageal cancer patients: quantitative assay system and potential clinical utility.
    Clin Cancer Res. 2007;13:2992-7.
    PubMed     Related articles    Abstract available
    
    
    
57. VACHANI A , Nebozhyn M, Singhal S, Alila L, et al
    A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma.
    Clin Cancer Res. 2007;13:2905-15.
    PubMed     Related articles    Abstract available
    
    
    
58. EKEBLAD S , Sundin A, Janson ET, Welin S, et al
    Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.
    Clin Cancer Res. 2007;13:2986-91.
    PubMed     Related articles    Abstract available
    
    
    
59. ZHOU G , Zhai Y, Cui Y, Zhang X, et al
    MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population.
    Clin Cancer Res. 2007;13:2627-33.
    PubMed     Related articles    Abstract available
    
    
    April 2007
60. FENG FY , Lopez CA, Normolle DP, Varambally S, et al
    Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivo.
    Clin Cancer Res. 2007;13:2512-8.
    PubMed     Related articles    Abstract available
    
    
    
61. LIU W , Baer MR, Bowman MJ, Pera P, et al
    The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
    Clin Cancer Res. 2007;13:2463-70.
    PubMed     Related articles    Abstract available
    
    
    March 2007
62. WOLF JS , Li G, Varadhachary A, Petrak K, et al
    Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo.
    Clin Cancer Res. 2007;13:1601-10.
    PubMed     Related articles    Abstract available
    
    
    
63. MA J , Liu L, Tang L, Zong J, et al
    Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories.
    Clin Cancer Res. 2007;13:1445-52.
    PubMed     Related articles    Abstract available
    
    
    February 2007
64. LIU D , Hu S, Hou P, Jiang D, et al
    Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant.
    Clin Cancer Res. 2007;13:1341-9.
    PubMed     Related articles    Abstract available
    
    
    
65. TANAKA E , Hashimoto Y, Ito T, Kondo K, et al
    The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma.
    Clin Cancer Res. 2007;13:1331-40.
    PubMed     Related articles    Abstract available
    
    
    
66. BEGUM S , Gillison ML, Nicol TL, Westra WH, et al
    Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
    Clin Cancer Res. 2007;13:1186-91.
    PubMed     Related articles    Abstract available
    
    
    
67. RIGHINI CA , de Fraipont F, Timsit JF, Faure C, et al
    Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
    Clin Cancer Res. 2007;13:1179-85.
    PubMed     Related articles    Abstract available
    
    
    
68. HOU P , Liu D, Shan Y, Hu S, et al
    Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
    Clin Cancer Res. 2007;13:1161-70.
    PubMed     Related articles    Abstract available
    
    
    
69. LUTHRA MG , Ajani JA, Izzo J, Ensor J, et al
    Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancers.
    Clin Cancer Res. 2007;13:912-9.
    PubMed     Related articles    Abstract available
    
    
    January 2007
70. SEIWERT TY , Connell PP, Mauer AM, Hoffman PC, et al
    A phase I study of pemetrexed, Carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.
    Clin Cancer Res. 2007;13:515-22.
    PubMed     Related articles    Abstract available
    
    
    
71. LIAO WT , Song LB, Zhang HZ, Zhang X, et al
    Centromere protein h is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
    Clin Cancer Res. 2007;13:508-14.
    PubMed     Related articles    Abstract available
    
    
    
72. LAO-SIRIEIX P , Lovat L, Fitzgerald RC
    Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance.
    Clin Cancer Res. 2007;13.
    PubMed     Related articles    Abstract available
    
    
    
73. LOGES S , Clausen H, Reichelt U, Bubenheim M, et al
    Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis.
    Clin Cancer Res. 2007;13:76-80.
    PubMed     Related articles    Abstract available
    
    
    December 2006
74. WILLIAMS MD , Chakravarti N, Kies MS, Maruya S, et al
    Implications of methylation patterns of cancer genes in salivary gland tumors.
    Clin Cancer Res. 2006;12:7353-8.
    PubMed     Related articles    Abstract available
    
    
    
75. WU X , Gu J, Dong Q, Huang M, et al
    Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer.
    Clin Cancer Res. 2006;12:7194-201.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    November 2006
76. SUGITO N , Ishiguro H, Kuwabara Y, Kimura M, et al
    RNASEN Regulates Cell Proliferation and Affects Survival in Esophageal Cancer Patients.
    Clin Cancer Res. 2006;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
77. POH CF , Zhang L, Anderson DW, Durham JS, et al
    Fluorescence Visualization Detection of Field Alterations in Tumor Margins of Oral Cancer Patients.
    Clin Cancer Res. 2006;12:6716-6722.
    PubMed     Related articles    Abstract available
    
    
    
78. HU JC , Coffin RS, Davis CJ, Graham NJ, et al
    A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor.
    Clin Cancer Res. 2006;12:6737-47.
    PubMed     Related articles    Abstract available
    
    
    
79. KUJAN O , Oliver R, Roz L, Sozzi G, et al
    Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
    Clin Cancer Res. 2006;12:6723-9.
    PubMed     Related articles    Abstract available
    
    
    
80. PERRONE F , Suardi S, Pastore E, Casieri P, et al
    Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.
    Clin Cancer Res. 2006;12:6643-51.
    PubMed     Related articles    Abstract available
    
    
    
81. HAMILTON JP , Sato F, Jin Z, Greenwald BD, et al
    Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.
    Clin Cancer Res. 2006;12:6637-42.
    PubMed     Related articles    Abstract available
    
    
    
82. WESTRA WH , Sidransky D
    Fluorescence visualization in oral neoplasia: shedding light on an old problem.
    Clin Cancer Res. 2006;12:6594-7.
    PubMed     Related articles   
    
    
    
83. FUJITA Y , Nakanishi T, Hiramatsu M, Mabuchi H, et al
    Proteomics-Based Approach Identifying Autoantibody against Peroxiredoxin VI as a Novel Serum Marker in Esophageal Squamous Cell Carcinoma.
    Clin Cancer Res. 2006;12:6415-20.
    PubMed     Related articles    Abstract available
    
    
    
84. UNRYN BM , Hao D, Gluck S, Riabowol KT, et al
    Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer.
    Clin Cancer Res. 2006;12:6345-50.
    PubMed     Related articles    Abstract available
    
    
    
85. SIMS-MOURTADA J , Izzo JG, Apisarnthanarax S, Wu TT, et al
    Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.
    Clin Cancer Res. 2006;12:6565-72.
    PubMed     Related articles    Abstract available
    
    
    October 2006
86. SETOYAMA T , Natsugoe S, Okumura H, Matsumoto M, et al
    Carcinoembryonic antigen messenger RNA expression in blood predicts recurrence in esophageal cancer.
    Clin Cancer Res. 2006;12:5972-7.
    PubMed     Related articles    Abstract available
    
    
    
87. TIJINK BM , Buter J, de Bree R, Giaccone G, et al
    A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus.
    Clin Cancer Res. 2006;12:6064-72.
    PubMed     Related articles    Abstract available
    
    
    
88. OHSHIRO K , Rayala SK, Williams MD, Kumar R, et al
    Biological role of estrogen receptor beta in salivary gland adenocarcinoma cells.
    Clin Cancer Res. 2006;12.
    PubMed     Related articles    Abstract available
    
    
    
89. ZIOBER AF , Patel KR, Alawi F, Gimotty P, et al
    Identification of a gene signature for rapid screening of oral squamous cell carcinoma.
    Clin Cancer Res. 2006;12.
    PubMed     Related articles    Abstract available
    
    
    
90. ANDERSON MR , Harrison R, Atherfold PA, Campbell MJ, et al
    Met receptor signaling: a key effector in esophageal adenocarcinoma.
    Clin Cancer Res. 2006;12.
    PubMed     Related articles    Abstract available
    
    
    
91. HYER ML , Samuel T, Reed JC
    The FLIP-side of Fas signaling.
    Clin Cancer Res. 2006;12.
    PubMed     Related articles   
    
    
    
92. YANG Z , Schumaker LM, Egorin MJ, Zuhowski EG, et al
    Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.
    Clin Cancer Res. 2006;12:5817-25.
    PubMed     Related articles    Abstract available
    
    
    
93. SCHRUMP DS , Fischette MR, Nguyen DM, Zhao M, et al
    Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.
    Clin Cancer Res. 2006;12:5777-85.
    PubMed     Related articles    Abstract available
    
    
    
94. YIP KW , Shi W, Pintilie M, Martin JD, et al
    Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
    Clin Cancer Res. 2006;12:5726-32.
    PubMed     Related articles    Abstract available
    
    
    September 2006
95. RAJENDRAN JG , Schwartz DL, O'Sullivan J, Peterson LM, et al
    Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.
    Clin Cancer Res. 2006;12:5435-41.
    PubMed     Related articles    Abstract available
    
    
    
96. ZHANG Z , Wang LE, Sturgis EM, El-Naggar AK, et al
    Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
    Clin Cancer Res. 2006;12:5596-602.
    PubMed     Related articles    Abstract available
    
    
    
97. LUONG QT , O'Kelly J, Braunstein GD, Hershman JM, et al
    Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
    Clin Cancer Res. 2006;12:5570-7.
    PubMed     Related articles    Abstract available
    
    
    
98. YIP KW , Mao X, Au PY, Hedley DW, et al
    Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Clin Cancer Res. 2006;12:5557-69.
    PubMed     Related articles    Abstract available
    
    
    July 2006
99. KWAK EL , Jankowski J, Thayer SP, Lauwers GY, et al
    Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas.
    Clin Cancer Res. 2006;12.
    PubMed     Related articles    Abstract available
    
    
    June 2006
100. YOUNES MN , Yazici YD, Kim S, Jasser SA, et al
     Dual Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Inhibition with NVP-AEE788 for the Treatment of Aggressive Follicular Thyroid Cancer.
     Clin Cancer Res. 2006;12:3425-34.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
101. CERUTTI JM , Latini FR, Nakabashi C, Delcelo R, et al
     Diagnosis of Suspicious Thyroid Nodules Using Four Protein Biomarkers.
     Clin Cancer Res. 2006;12:3311-3318.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     April 2006
102. JUNG K
     Impact of blood sampling on circulating tissue inhibitors of metalloproteinases.
     Clin Cancer Res. 2006;12:2648.
     PubMed     Related articles   
     
     
     
103. GARREL R , Dromard M, Costes V, Barbotte E, et al
     The diagnostic accuracy of reverse transcription-PCR quantification of cytokeratin mRNA in the detection of sentinel lymph node invasion in oral and oropharyngeal squamous cell carcinoma: a comparison with immunohistochemistry.
     Clin Cancer Res. 2006;12:2498-505.
     PubMed     Related articles    Abstract available
     
     
     March 2006
104. OUYANG B , Knauf JA, Smith EP, Zhang L, et al
     Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with RET/PTC or BRAF Mutations In vitro and In vivo.
     Clin Cancer Res. 2006;12:1785-93.
     PubMed     Related articles    Abstract available
     
     
     
105. CHILOECHES A , Marais R
     Is BRAF the Achilles' Heel of Thyroid Cancer?
     Clin Cancer Res. 2006;12:1661-4.
     PubMed     Related articles   
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: